Prognostic and predictive markers in patients with advanced metastatic tumors
This study will research possible associations between circulating tumor cells (CTC) quantities or gene profile characteristics and clinical outcomes.
The primary objective is to obtain blood samples from participants over an 8-week period for research analysis.
The study will enroll approximately 200 patients at the CTRC.
In addition to other conditions for enrollment, eligible patients have advanced metastatic cancer.
To enroll or if you have questions about participation